Innovent Oncology Program Sheets


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Innovent Oncology Program Sheets

  1. 1. Level I Pathways Drug Cost is Only the Ground Floor Oncology care is evolving faster than ever. Emerging drugs and technologies are driving new treatment options for oncologists and their patients. Some are promising yet some are not. Knowing which ones offer true clinical benefit is critical to optimizing outcomes and managing costs. The focus on drug reimbursement is one important and necessary way of addressing costs. But this approach does not prevent “jumping to the next drug” and does little to address the vast treatment variation seen in oncology. The real clinical and cost opportunity is in using the right treatments in the first place. Level I Pathways: The Next Step Level I Pathways from Innovent Oncology are the next step in managing quality and cost. Moving beyond broad label listings and public domain guidelines, Level I Pathways narrow the options to those with proven clinical effectiveness and the least possible toxicity. When Level I evidence* points to a superior drug that is the one that is used. If there is no clear evidence of clinical superiority, then drug toxicity and cost are factored into the pathway. Community Oncologists Agree: Consensus Means Adoption Clinical oncology is increasingly complex. Level I Pathways are developed and updated by a National Policy Board from a network of more than 1,000 practicing community oncologists. Their work is an ongoing, exhaustive review of documented clinical evidence from an array of sources including medical journals, outcomes data and network experience. The result of this process is a national treatment standard rooted in evidence and supported by more than 18 industry accepted outcomes measures. The result for payers is local application by community oncologists working to limit the treatment variation that drives substandard quality and unnecessary costs. Technology Options: Compliance Drives Value Innovent Oncology provides options that enable payers and oncologists to use Level I Pathways for oncology drug selection within the oncologist’s practice. These technologies allow access to decision support tools for treatment selection and data sharing essential to compliance documentation. • Direct Electronic Medical Records (EMR) access • EMR connectivity • Oncology 837: Interactive Web Portal • Adherence report engine* Level I evidence is obtained from meta-analysis of multiple, well-designed, controlled studies or from randomized trials with low false-positive and low false-negative errors (high power). Integrated Cancer Solutions
  2. 2. Level I Pathways Features Benefits Expected Results • Physician-led, expert driven • Refined guidelines limit variance • Value-based therapy choices development • Oncologist-derived consensus • Reduced diagnostic testing utilization • Broad, deep and ongoing evidence promotes physician adoption and costs review • Clear, credible clinical standards • Reduced overall treatment costs • Narrowed subset of label listings and inform utilization policy public guidelines • Reduced drug testing utilization • Documented treatment comparisons and costs • Defines line of therapy based on identify physician compliance cancer stage, current patient status • Effectiveness and toxicity first, cost second Evidence-based Oncology: A New Level of Refinement Convenient, easy-to-use web portal captures additional diagnosis and treatment information at the point of care. "We’ve worked with oncologists and payers nationwide to develop this program,” says Marcus A. Neubauer, MD, Chairman of US Oncology’s Level I Pathways committee and medical oncologist with Kansas City Cancer Centers. “The physicians affiliated with US Oncology developed evidence-based treatment pathways several years ago to reduce the high variability of drug utilization during treatment, but this program goes well beyond drug utilization in its quest for improved quality and reduced costs." Marcus A. Neubauer, MD For more information about theIntegrated Cancer Solutions available from Innovent Oncology: Call: (866) 214-2194Email: • Integrated Cancer Solutions
  3. 3. Advance Care Planning Informing Transitions: The Direct Path The cancer path is paved with many frightening twists and turns. Do I understand the possible course of events? As each unfolds, do I know the choices I will make? Am I ready to face my personal circumstances? Advance Care Planning helps patients explore these questions within the context of their specific disease, understand their options and document their preferences for end-of-life care. Along with their caregivers and family members, patients specify the treatments they do and do not desire and select a healthcare agent to speak on their behalf when necessary. Beyond Costs, Peace of Mind for Everyone Only one-third of terminally ill cancer patients in a recent, federally funded study said their doctors had discussed end-of-life care.* Trained to help patients fight their disease, oncologists are routinely confronted by the end-of-life issues of patients and their loved ones. Some oncologists do it with ease. Others can’t do it at all. It’s one of the most difficult things for everyone involved. Yet, doing so has clear benefits that go far beyond the associated costs of eliminating futile treatment during the last months of life. Innovent Oncology Advance Care Planning is designed to facilitate timely, sensitive discussions with patients and loved ones as they confront transition from active/curative treatment to palliative care. The very same care team that guides patients through their fight to overcome their cancer introduces end-of-life concepts to patients. They review treatment options, discuss Advance Directives, and prepare for palliative care and hospice. These discussions empower patients, increase their satisfaction with care and give everyone peace of mind. Practical Guidance for End-of-Life Care In the same recent end-of-life study, early findings show the promise of open, objective communication and documentation of patient preferences for care. Those patients who had end-of-life talks were three times less likely to spend their final week in intensive care, four times less likely to be on breathing machines and six times less likely to be resuscitated. Innovent Oncology Advance Care Planning is designed to equip oncologists with the tools to guide patients and their loved ones along a path of discovery near the end-of-life.* Alexi A. Wright, MD et al Integrated Cancer Solutions
  4. 4. Advance Care Planning Features Benefits Expected Results • Introduce end of life (EOL) • Introduce and review Advance • Reduced overall costs associated concepts early Directives with EOL care • Introduce and review Advance • Reinforce best standards of care • Increased hospice utilization Directives • Prepare patient, family and care • Increased use of Advance Directives • Involve physician and qualified team for advanced disease state non-physician professionals • Increased patient and family comfort, • Open option of clinical trials peace of mind and satisfaction • Hold specific EOL discussions with care • Ease patient EOL distress • Implement Palliative Care Plan and • Avoidance of costly, futile care hospice care as appropriate • Ensure appropriate services delivery • Empower patients and increase satisfaction with care Team-based, Compassionate Care. Patients and their care team have tools to facilitate preparation for advanced disease state. “We recognize we will not be able to cure all of our cancer patients. We can, however, provide care that helps them live life as well as they can,” says Russell Hoverman, MD, Medical Director of Managed Care with US Oncology and medical oncologist with Texas Oncology. “The tools provided by Innovent Oncology enhance our ability to help our patients by supporting a team-based approach to the delivery of our goal of compassionate care.” Russell Hoverman, MD For more information about theIntegrated Cancer Solutions available from Innovent Oncology: Call: (866) 214-2194Email: • Integrated Cancer Solutions
  5. 5. Patient Support Services Touch the Patient, Heal the System During their treatment, cancer patients are often confronted with more than they can handle. Managing the physical impacts of the disease, its impact on their lives and those around them, and their treatment plan—potentially including potent, home-administered oral chemotherapy—is daunting. What will happen next? Can I really handle chemotherapy? How will I know what side effects to watch for and how to manage them? What if something goes wrong? The inability to manage through these issues can result in unnecessary patient and family distress, unplanned, frightening trips to the emergency room, or worse, a hospitalization. These events are hard on patients and costly to our healthcare system. Proactive management to limit patient fear and anxiety while ensuring efficient resource utilization is the purpose of Innovent Oncology Patient Support Services.Physician-Directed Disease Management The full promise of disease management is realized when informed by the oncologist’s plan of care. Patients need clear information that reinforces what they have already heard from their trusted oncologist. Innovent Oncology Patient Support Services are integrated with and initiated by the oncology care team. Focused education specific to the patient’s disease is delivered by oncology certified registered nurses using evidence-based, standardized education materials. Patients receive regular outreach and support tailored to their disease, their specific drug regimen and potential side effects.Technology Enabled: Practice-Integrated and Call Center Supported Innovent Oncology provides technologies to better connect the oncology care team with their patients. The resulting interactive decision support and data sharing drives proactive patient monitoring, care team interventions, and patient compliance documentation. • Direct Electronic Medical Records (EMR) views by registered nurse care manager • CRM connectivity, alerts and patient status views • Call center support • Print and web patient education content Integrated Cancer Solutions
  6. 6. Patient Support Services Features Benefits Expected Results • Physician directed and integrated • Extend proactive engagement to • Increased adherence and with care plan members between office visits compliance to treatment plan • Focused education and intervention • Increased member confidence in • Improved health status by cancer specialist at-home management • Reduced unplanned office visits • Practice-based and/or call • Ensure most appropriate services center-supported utilization • Reduced ER visits, hospitalizations and hospital days • Patient-specific disease and • Consolidate excessive care treatment counseling management contacts • Increased patient and physician satisfaction • Evidence-based, standardized • Broader program participation education materials • Drug specific information • Side effect profile and plan • Nutrition education Improving Care. Managing Costs. Patients receive standardized education materials that increase their confidence in at-home management of their disease. “We all want the same thing—the most effective, compassionate care possible for cancer patients and their families as they go through what can be a very frightening experience,” says Michael A. Kolodziej, MD, Medical Director for US Oncology and medical oncologist with New York Oncology Hematology. “This comprehensive approach helps providers and payers work together to focus on patient services in a way that will improve patient care and manage costs at the same time.” Michael A. Kolodziej, MD For more information about theIntegrated Cancer Solutions available from Innovent Oncology: Call: (866) 214-2194Email: • Integrated Cancer Solutions